The global FIH trials race, a Back to School podcast special

• Risk and regulatory redesign — Transforming first-in-human trials requires shifting from overlapping control-heavy review systems toward models that preserve safety while enabling faster access to early clinical data

• Global competition in early trials — China, Australia, and emerging European hubs are forcing the U.S. and others to modernize trial start-up, patient enrollment, and review processes to remain competitive for innovation and investment...